Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog



1232 Features
Diabetes: time for a new regime?

22 Jan 03

In 2001, diabetes drugs represented six of the leading 100 pharmaceutical brands in terms of global sales, combining for $8.2 billion in sales. Sales were led by Bristol-Myers Squibb's Glucophage fran
Michael Randle

Therapeutic Advances: 10th January 2003

15 Jan 03

The current edition of TherapeuticAdvances features data on anti-migraine drugs; emerging approaches to the blockade of transcription, angiogenesis and metastasis; and two therapeutic strategies for t
Dr Jon Goldhill

The Best in Class?

15 Jan 03

Is GSK a thrusting new pharma co or an ageing dinosaur? Pfast Forward went to the UK HQ to find out.

Smallpox vaccines: to invest or not to invest, tha

13 Jan 03

During the last year bioterrorism has attracted a high level of media and clinical attention. However, this publicity does not necessarily reflect a potential opportunity for easy market entry or high
Michael Randle

National Health Service: handling heart failure

17 Dec 02

The number of people with chronic heart failure in the western world is increasing so rapidly that, according to Datamonitor's EpiVision forecasts, by 2015 there will be 1.5 million sufferers in the UK alone. Although this is small in comparison to the 8.2 million already suffering from the condition in the US, the problem is great enough to represent a real danger for the already beleaguered NHS.
Johan Short

Medical Devices and Clinical Trials: Exploring a N

13 Dec 02

As the medical device field becomes more advanced the need for clinical trials will grow. With less experience of global clinical trials than those in the pharmaceutical sector, medical device compani
Dr Faiz Kermani and Jeff Kingston

Man or Mouse?

10 Dec 02

The scientific community seemed to move into overdrive with the publication of the human genome, and the popular media responded this with reports of rapid advances to come in the field of human medic
Paul Hartigan

Big pharma: tightening the marketers' purse strings

06 Dec 02

According to new research pharmaceutical companies are investing more than ever to promote their drugs. Growth in promotional investment is thought to be increasing at a faster rate than growth in ethical sales. With this trend unlikely to continue because of economic constraint can the drug companies increase the impact of their marketing or do they face the prospect of slashing expenditure?
Michael Randle

eHealth News Roundup for 18th - 29th November 2002

03 Dec 02

The healthcare industry is increasingly looking to take advantage of the Internet and one of the leading pharmaceutical groups is leading the way. Schering-Plough has recognized the potential benefit
Johan Short

Cancer: Iressa prepares for a rush of blood

03 Dec 02

Despite significant initial interest in angiogenesis inhibitors, they have failed to live up to expectations and are yet to be approved by the FDA for cancer treatment. However, there are a number of
Johan Short

Patient Recruitment: The New Challenge in Clinical Research

22 Nov 02

Patient enrollment is of continued interest, as many companies believe it is possible to improve clinical cycle times by compressing the enrolment period. However, this means recognizing the fact that the nature of the trial will affect the recruitment period and so the degree of improvement that can be made will differ from trial to trial.
Pietro Bonacossa and Faiz Kermani

Senior Executive Recruitment

20 Nov 02

Lets have a look at the healthcare market and some of the things that are changing within it and then assess the impact of the changes on companies’ ability to achieve effective recruitment.
Peter Fortune

TherapeuticAdvances: 14th November, 2002

20 Nov 02

This week’s TherapeuticAdvances focuses on histone deacetylase inhibitors; in particular their use as antifungal as well as anti-metastatic agents. We also feature compelling data supporting the use o
Jon Goldhill

QP or not QP – a career worth considering

15 Nov 02

Demand for QPs has increased dramatically in the last 10-15 years as a result of an aging demographic in this role.
Jeff Webb - PIR Group

Glycogen synthase kinase 3 inhibitors: Proof of co

08 Nov 02

Since the mid-1990s there has been a near exponential rise in the level of glycogen synthase kinase-3 (GSK-3) related research. Consequently the therapeutic potential of GSK-3 inhibitors has become a
Dr Jon Goldhill

QPs Have Never Had it So Good: Four-Wheeled Benefi

07 Nov 02

PiR Group has released the essential guide to Qualified Persons (QP) salary and benefits - The 2002 QP Salary Survey & Report. The data reveals that there is no longer a 'north/south divide' but more
Anna Munford

How to manage your relationship with recruitment a

29 Oct 02

Your relationship with recruitment agencies and consultants is of critical importance if you are to quickly secure employment. This article will help you to better understand the dynamics of this rela
Jeremy Tromans

Why e-Detailing and what every sales rep needs to

29 Oct 02

Taking an in-depth look into a new media channel that could change the pharmaceutical industry
Richard Trio

HMP-12 an adrenoceptor antagonist for the treatmen

25 Oct 02

LeadDiscovery is pleased to announce the completion of it's most recent DiscoveryDossier describing a new licensing or co-development opportunity relating the treatment of erectile dysfunction and fem
Dr Jon Goldhill

Therapeutic Advances: 17th October 2002

24 Oct 02

This week’s TherapeuticAdvances focuses on new targets for Alzheimer's disease. In particular the topic of the moment, GSK-3 (which is also featured in our recent DiscoveryDossier) and clusterin have
Dr Jon Goldhill

Conference calling

20 Oct 02

A successful conference can play a vital part in the sometimes onerous management task of keeping employees motivated and well trained and in the last decade conferences have become an essential part
Mark Stacey

TherapeuticAdvances: 4th October, 2002

11 Oct 02

This week we focus on new targets for asthma (MMP-9 & LXA4). We also identify emerging approaches to the unmet CNS diseases, Alzheimer's disease (Protein phosphatase 1) and stroke (ATII receptor antag
Dr Jon Goldhill

How to Recruit Winning Clinical Staff

11 Oct 02

The pharmaceutical industry is one of the most highly R&D-intensive industries, more so than the electronics, communications, and aerospace industries. The industry faces a continuing challenge in emp
Dr Faiz Kermani

Time to Move On?

02 Oct 02

You could spend days trawling through the situations vacant, ringing and writing to prospective employers “on spec” and buying numerous beers for your buddies in return for their “putting a good word
Elaine Ford
Futures Resourcing

TherapeuticAdvances: 19th September 2002

27 Sep 02

This week’s TherapeuticAdvances focuses on emerging indications for histone deacetylase modulators including breast cancer and asthma. In addition we feature premature ejaculation, an indication that
Dr Jon Goldhill, LeadDiscovery

e-Detailing: Revolutionizing Professional Healthcare

26 Sep 02

It has been an interesting journey for e-detailing; something that has for a while now been hyped as the ‘killer’ e-business application for today’s pharmaceutical sales & marketing teams with which t
Colin Williams

Angiotensin as a target for the treatment of Alzhe

24 Sep 02

Mental disorders affect 44.3 million Americans in a given year. According to analysts the current global CNS therapeutics market is estimated at $40-55 billion, accounting for around 15% of the total
Dr Jon Goldhill

Male and female sexual dysfunction: Blockbuster in

24 Sep 02

In March, 1998, Pfizer launched sildenafil (Viagra) for the treatment of erectile dysfunction. This move had an explosive effect on Pfizer's financial figures. More generally, this pharmaceutical mile
Dr Jon Goldhill

Get that job in the Pharma Industry!!

29 Aug 02

The day of your interview for your dream job has finally dawned. You’ve researched the role and the organisation, prepared your examples of skill and competency and polished your shoes!
Trudy Lowe

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.